Inventor
ANTONIA LOPEZ-GIRONA
Inventor
US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds13%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C07KPeptides6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology3%
C07BGeneral methods of organic chemistry2%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
PatentTitleYear
12,510,533Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile202512,474,342Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies202512,396,995Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use202512,178,822Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion202412,103,923Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione202412,029,738Antiproliferative compounds and methods of use thereof202411,945,804Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith202411,733,233Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases202311,726,080Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile202311,666,579Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione202311,628,172Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione202311,590,117Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide202311,583,536Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use202311,460,471Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies202211,419,861Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases202211,390,617Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione202211,358,952Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith202211,241,423Antiproliferative compounds and methods of use thereof202211,185,543Antiproliferative compounds and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CELGENE CORP (19)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 19 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 19 | 2021–2025 |